Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the Italian version of self-administered ALSFRS-R scale.
Manera U, Cabras S, Daviddi M, Vasta R, Torrieri MC, Palumbo F, Bombaci A, Grassano M, Solero L, Peotta L, Iazzolino B, Canosa A, Calvo A, Chiò A, Moglia C. Manera U, et al. Among authors: daviddi m. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Feb;22(1-2):151-153. doi: 10.1080/21678421.2020.1813307. Epub 2020 Aug 28. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32856494
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience.
Vasta R, Moglia C, D'Ovidio F, Di Pede F, De Mattei F, Cabras S, Peotta L, Iazzolino B, Giusiano S, Manera U, Palumbo F, Bombaci A, Torrieri MC, Ilardi A, Mastro E, Arcari M, Solero L, Grassano M, Daviddi M, Matteoni E, Salamone P, Fuda G, Canosa A, Chiò A, Calvo A. Vasta R, et al. Among authors: daviddi m. Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):308-311. doi: 10.1080/21678421.2020.1820043. Epub 2020 Sep 12. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32924624
Amyotrophic lateral sclerosis caregiver burden and patients' quality of life during COVID-19 pandemic.
Giusiano S, Peotta L, Iazzolino B, Mastro E, Arcari M, Palumbo F, Torrieri MC, Bombaci A, Grassano M, Cabras S, Di Pede F, DeMattei F, Matteoni E, Solero L, Daviddi M, Salamone P, Fuda G, Manera U, Canosa A, Chiò A, Calvo A, Moglia C, Vasta R. Giusiano S, et al. Among authors: daviddi m. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):146-148. doi: 10.1080/21678421.2021.1912772. Epub 2021 Apr 16. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 33860702
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring.
Manera U, Torrieri MC, Moglia C, Viglione M, Daviddi MAR, Matteoni E, Solero L, Palumbo F, Vasta R, Canosa A, D'Ovidio F, Focaraccio L, Mattei A, Mora G, Calvo A, Chio A. Manera U, et al. Among authors: daviddi mar. J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):999-1000. doi: 10.1136/jnnp-2020-323810. Epub 2020 Jun 30. J Neurol Neurosurg Psychiatry. 2020. PMID: 32605931 Free article. No abstract available.
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
Salamone P, Fuda G, Casale F, Marrali G, Lunetta C, Caponnetto C, Mazzini L, La Bella V, Mandrioli J, Simone IL, Moglia C, Calvo A, Tarella C, Chio A; STEMALS-II Study Group. Salamone P, et al. BMJ Open. 2020 Mar 24;10(3):e034049. doi: 10.1136/bmjopen-2019-034049. BMJ Open. 2020. PMID: 32209625 Free PMC article.
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study.
Manera U, Calvo A, Daviddi M, Canosa A, Vasta R, Torrieri MC, Grassano M, Brunetti M, D'Alfonso S, Corrado L, De Marchi F, Moglia C, D'Ovidio F, Mora G, Mazzini L, Chiò A. Manera U, et al. Among authors: daviddi m. J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):291-297. doi: 10.1136/jnnp-2019-321153. Epub 2019 Dec 23. J Neurol Neurosurg Psychiatry. 2020. PMID: 31871138 Free article.
High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants.
Calvo A, Moglia C, Canosa A, Manera U, Vasta R, Grassano M, Daviddi M, De Mattei F, Matteoni E, Gallone S, Brunetti M, Sbaiz L, Cabras S, Peotta L, Palumbo F, Iazzolino B, Mora G, Chiò A. Calvo A, et al. Among authors: daviddi m. Ann Neurol. 2024 Jul;96(1):150-158. doi: 10.1002/ana.26928. Epub 2024 Apr 3. Ann Neurol. 2024. PMID: 38568044
Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant.
Moglia C, Calvo A, Canosa A, Manera U, Vasta R, Di Pede F, Daviddi M, Matteoni E, Brunetti M, Sbaiz L, Cabras S, Gallone S, Grassano M, Peotta L, Palumbo F, Mora G, Iazzolino B, Chio A. Moglia C, et al. Among authors: daviddi m. Neurology. 2024 Feb 27;102(4):e208082. doi: 10.1212/WNL.0000000000208082. Epub 2024 Jan 23. Neurology. 2024. PMID: 38261982 Free PMC article.
The role of peripheral immunity in ALS: a population-based study.
Grassano M, Manera U, De Marchi F, Cugnasco P, Matteoni E, Daviddi M, Solero L, Bombaci A, Palumbo F, Vasta R, Canosa A, Salamone P, Fuda G, Casale F, Mazzini L, Calvo A, Moglia C, Chiò A. Grassano M, et al. Among authors: daviddi m. Ann Clin Transl Neurol. 2023 Sep;10(9):1623-1632. doi: 10.1002/acn3.51853. Epub 2023 Jul 22. Ann Clin Transl Neurol. 2023. PMID: 37482930 Free PMC article.